Is Procalcitonin Biomarker-Guided Antibiotic Therapy a Cost-Effective Approach to Reduce Antibiotic Resistant and Clostridium difficile Infections in Hospitalized Patients?

Lotte Steuten, Janne Mewes, Isabelle Lepage-Nefkens, Hubertus Vrijhoef

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)616-625
Number of pages10
JournalOMICS-a journal of Integrative Biology
Volume22
Issue number9
DOIs
Publication statusPublished - 1 Sep 2018

Keywords

  • procalcitonin
  • biomarkers
  • antibiotic stewardship
  • economic evaluation
  • sepsis
  • chronic obstructive pulmonary disease
  • RESPIRATORY-TRACT INFECTIONS
  • RANDOMIZED CONTROLLED-TRIAL
  • INTENSIVE-CARE-UNIT
  • SERUM PROCALCITONIN
  • ECONOMIC BURDEN
  • SEPSIS
  • ALGORITHM
  • HEALTH
  • ADULTS
  • METAANALYSIS

Cite this